T-Therapeutics Funding: $91M Raised, Series A (2024)
T-Therapeutics is based in Cambridge, England. It has raised $91M in total funding. Latest round: Series A.
T-Therapeutics funding overview
T-Therapeutics is based in Cambridge, England. T-Therapeutics has raised $91M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2024. The round record for T-Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Sofinnova Partners, F-Prime Capital, Digitalis Ventures, Cambridge Innovation Capital, Sanofi Ventures, Tencent and 2 others. 8 distinct backers are named across the disclosed rounds.
T-Therapeutics at a glance
Total raised
$91M
Latest round
Series A
Latest round date
December 2024
Headquarters
Cambridge, England
Notable investors
Sofinnova Partners, F-Prime Capital, Digitalis Ventures, Cambridge Innovation Capital, Sanofi Ventures, Tencent, BGF, University of Cambridge Venture Fund
Frequently asked about T-Therapeutics funding
How much has T-Therapeutics raised?
T-Therapeutics has raised $91M in total disclosed funding across the rounds on record.
Who has invested in T-Therapeutics?
Sofinnova Partners, F-Prime Capital, Digitalis Ventures, Cambridge Innovation Capital, Sanofi Ventures, Tencent are named among the investors backing T-Therapeutics.
What was the latest T-Therapeutics funding round?
The most recent disclosed round is a Series A, announced in December 2024.
Where is T-Therapeutics based?
T-Therapeutics is based in Cambridge, England.
When did T-Therapeutics last raise?
The last disclosed T-Therapeutics round closed in December 2024 at Series A.
T-Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.
